Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance.
- NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_assertion description "[We have found previously that development of the drug resistance and metastatic phenotypes in breast cancer cells is associated with increased tissue transglutaminase (TG2) expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance.
- NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_assertion evidence source_evidence_literature NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance.
- NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_assertion SIO_000772 16818508 NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance.
- NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_assertion wasDerivedFrom befree-2016 NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance.
- NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_assertion wasGeneratedBy ECO_0000203 NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance.
- befree-2016 importedOn "2016-02-19" NP557816.RAUSra7MaWYxAcgW_LX-PtWa90222vsrmINJ6i5b_bAn4130_provenance.